Effectiveness of high-dose versus standard-dose influenza vaccines against severe respiratory and secondary cardiovascular outcomes in adults aged ≥80 years

Clinical Microbiology and Infection · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles